Pages that link to "Q38114629"

The following pages link to Serum testosterone levels after medical or surgical androgen deprivation: a comprehensive review of the literature (Q38114629):

Displaying 19 items.

• Maximal testosterone suppression in the management of recurrent and metastatic prostate cancer (Q29994552) (← links)
• Improving treatment strategies for patients with metastatic castrate resistant prostate cancer through personalized computational modeling (Q33589156) (← links)
• Testosterone monitoring for men with advanced prostate cancer: Review of current practices and a survey of Canadian physicians (Q33803812) (← links)
• Maximal testosterone suppression in prostate cancer--free vs total testosterone (Q35096022) (← links)
• (18)F-fluoride positron emission tomography/computed tomography and bone scintigraphy for diagnosis of bone metastases in newly diagnosed, high-risk prostate cancer patients: study protocol for a multicentre, diagnostic test accuracy study (Q35890956) (← links)
• AR-Signaling in Human Malignancies: Prostate Cancer and Beyond (Q37629545) (← links)
• Inhibition of the androgen receptor by mineralocorticoids at levels physiologically achieved in serum in patients treated with abiraterone acetate (Q38973231) (← links)
• Androgen Signaling in Prostate Cancer (Q39227656) (← links)
• Evaluation of the effectiveness of adding androgen deprivation to modern dose-escalated radiotherapy for men with favorable intermediate-risk prostate cancer (Q39756984) (← links)
• Depressive symptoms are found to be potential adverse effects of androgen deprivation therapy in older prostate cancer patients: A 15-month prospective, observational study. (Q47896453) (← links)
• Hormone levels following surgical and medical castration: defining optimal androgen suppression (Q50125356) (← links)
• Testosterone suppression in the treatment of recurrent or metastatic prostate cancer - A Canadian consensus statement. (Q52572665) (← links)
• Free Testosterone During Androgen Deprivation Therapy Predicts Castration-Resistant Progression Better Than Total Testosterone. (Q53762958) (← links)
• Establishing an Animal Model of Secondary Osteoporosis by Using a Gonadotropin-releasing Hormone Agonist. (Q55015269) (← links)
• Discordance between testosterone measurement methods in castrated prostate cancer patients (Q61811009) (← links)
• Membrane-associated androgen receptor (AR) potentiates its transcriptional activities by activating heat shock protein 27 (HSP27) (Q89206208) (← links)
• Second brazilian consensus on the treatment of advanced prostate cancer - a SBOC-SBU-SBRT panel review (Q91640748) (← links)
• Androgen Receptor Dependence (Q92410955) (← links)
• (Q93600794) (← links)